Rosetta Genomics announces patent for gene expression signature to distinguish four types of kidney cancer
The ability to more accurately define the different types of cancer, it could lead to lowering costs for treatment and reducing complications.
Rosetta Genomics to raise $2 million in private stock sale
Rosetta Genomics (NASDAQ:ROSG) announced it is selling $1.9 million in securities in a private placement following a restructuring intended to reduce operating expenses announced earlier this week. The company is a developer and provider of microRNA-based molecular diagnostics and is headquartered in Rehovot, Israel with offices in Philadelphia. Earlier this week the company announced a […]
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.